Literature DB >> 11745459

FGF-1 and FGF-2 regulate the expression of E-cadherin and catenins in pancreatic adenocarcinoma.

I El-Hariry1, M Pignatelli, N R Lemoine.   

Abstract

E-cadherin is a transmembrane protein that mediates Ca2+-dependent cell-cell adhesion and is implicated in a number of biologic processes, including cell growth and differentiation, cell recognition and cell sorting during development. We have previously demonstrated that both cell-cell adhesion and invasion are modulated by fibroblast growth factor (FGF)-1 and FGF-2 in a panel of pancreatic adenocarcinoma cell lines (BxPc3, T3M4 and HPAF). Here, we examine further the role of FGFs in the expression and activation of the E-cadherin/catenin system. We demonstrate that both FGF-1 and FGF-2 upregulate E-cadherin and beta-catenin at the protein level in the BxPc3 and HPAF cell lines and modestly in T3M4 cells. FGF-1 and FGF-2 facilitate the association of E-cadherin and alpha-catenin with the cytoskeleton, as demonstrated by the increase in the detergent-insoluble fraction of E-cadherin in BxPc3 and HPAF cells. Since the correct function of the E-cadherin/catenin complex requires its association with the cytoskeleton, our data suggest that FGF-1 and FGF-2 contribute to the integrity and thus the function of the complex. Furthermore, FGFs facilitate the assembly of the E-cadherin/catenin axis. The effect is associated with elevation of tyrosine phosphorylation of E-cadherin, alpha-catenin, beta-4051 mu-catenin and gamma-catenin, but not p120ctn. These findings indicate that the E-cadherin/catenin system is a target of the FGF/FGFR system and that coordinated signals from both systems may determine the ultimate biologic responses. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11745459     DOI: 10.1002/ijc.1515

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  14 in total

Review 1.  Molecular biology of pancreatic ductal adenocarcinoma progression: aberrant activation of developmental pathways.

Authors:  Andrew D Rhim; Ben Z Stanger
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

2.  Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis.

Authors:  Marco Chilosi; Venerino Poletti; Alberto Zamò; Maurizio Lestani; Licia Montagna; Paola Piccoli; Serena Pedron; Manuela Bertaso; Aldo Scarpa; Bruno Murer; Alessandra Cancellieri; Roberta Maestro; Gianpietro Semenzato; Claudio Doglioni
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

3.  Anterior gradient 2 downregulation in a subset of pancreatic ductal adenocarcinoma is a prognostic factor indicative of epithelial-mesenchymal transition.

Authors:  Yusuke Mizuuchi; Shinichi Aishima; Kenoki Ohuchida; Koji Shindo; Minoru Fujino; Masami Hattori; Tetsuyuki Miyazaki; Kazuhiro Mizumoto; Masao Tanaka; Yoshinao Oda
Journal:  Lab Invest       Date:  2014-11-24       Impact factor: 5.662

Review 4.  Target identification for CNS diseases by transcriptional profiling.

Authors:  C Anthony Altar; Marquis P Vawter; Stephen D Ginsberg
Journal:  Neuropsychopharmacology       Date:  2008-10-15       Impact factor: 7.853

5.  Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326.

Authors:  Jing Ke; Yi-long Yao; Jian Zheng; Ping Wang; Yun-hui Liu; Jun Ma; Zhen Li; Xiao-bai Liu; Zhi-qing Li; Zhen-hua Wang; Yi-xue Xue
Journal:  Oncotarget       Date:  2015-09-08

6.  Bone marrow mesenchymal stromal cells attenuate silica-induced pulmonary fibrosis potentially by attenuating Wnt/β-catenin signaling in rats.

Authors:  Enguo Zhang; Ye Yang; Shangya Chen; Cheng Peng; Martin F Lavin; Abrey J Yeo; Chao Li; Xiaoshan Liu; Yingjun Guan; Xinjing Du; Zhongjun Du; Hua Shao
Journal:  Stem Cell Res Ther       Date:  2018-11-14       Impact factor: 6.832

Review 7.  Fibroblast Growth Factor Receptors (FGFRs) and Noncanonical Partners in Cancer Signaling.

Authors:  Harriet R Ferguson; Michael P Smith; Chiara Francavilla
Journal:  Cells       Date:  2021-05-14       Impact factor: 6.600

8.  Anti-pancreatic cancer deliverables from sea: first-hand evidence on the efficacy, molecular targets and mode of action for multifarious polyphenols from five different brown-algae.

Authors:  Sheeja Aravindan; Caroline R Delma; Somasundaram S Thirugnanasambandan; Terence S Herman; Natarajan Aravindan
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

9.  Fgf2 is expressed in human and murine embryonic choroid plexus and affects choroid plexus epithelial cell behaviour.

Authors:  Sarah Greenwood; Adam Swetloff; Angela M Wade; Tetsuya Terasaki; Patrizia Ferretti
Journal:  Cerebrospinal Fluid Res       Date:  2008-12-29

10.  Effects of STI571 (gleevec) on pancreatic cancer cell growth.

Authors:  Junsheng Li; Jörg Kleeff; Junchao Guo; Lars Fischer; Nathalia Giese; Markus W Büchler; Helmut Friess
Journal:  Mol Cancer       Date:  2003-09-17       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.